Costello and
Noonan syndrome are similar to CFC and their phenotypic overlap may be due to the biochemical relationship of the genes mutated in each syndrome. Genes that are mutated in all three of these syndromes encode proteins that function in the
MAP kinase pathway. • Mutations that cause CFC are found in the
KRAS,
BRAF,
MEK1, and
MEK2 genes. • Costello syndrome is caused by mutations in
HRAS. • Mutations that cause Noonan syndrome have been found in
PTPN11 and
SOS1. The relative severity of CFC when compared to Noonan syndrome may reflect the position in the biochemical pathway occupied by the affected genes. • Shp2, the protein product of the PTPN11 gene, appears to regulate the MAP kinase pathway at or above the level of SOS1. • SOS1 in turn regulates the activities of
RAS,
RAF, MEK,
ERK, and
p90RSK. • SOS1 has been demonstrated to be a target of negative feedback by ERK and p90RSK. Thus, any activating mutation downstream of SOS1 may be subject to less regulation that might mitigate the consequence of such mutations, giving rise to the phenotypic differences seen between these syndromes. ==References==